Okediji, Paul
Troy, David
Heron, Jon
Kipping, Ruth R.
Martin, Richard M.
Wright, Caroline
Funding for this research was provided by:
Medical Research Council (MC_UU_00011/1, MC_UU_00011/3, MC_UU_00011/6, and MC_UU_00011/4, MC_UU_00011/1, MC_UU_00011/3, MC_UU_00011/6, and MC_UU_00011/4)
Cancer Research UK (C18281/A29019)
NIHR Bristol Biomedical Research Centre (BRC-1215-20011)
Article History
Received: 9 August 2023
Accepted: 18 December 2023
First Online: 5 January 2024
Declarations
:
: Ethical approval for the study was obtained from the ALSPAC Law and Ethics Committee (IRB00003312) and local Research Ethics Committees (for further details see ).Informed consent for the use of data collected via questionnaires and clinics was obtained from participants following the recommendations of the ALSPAC Ethics and Law Committee at the time. Further information, including consent forms can be found on the ALSPAC website (). Consent is assumed to be implied by the provision of self-report information, and participants are free to withdraw their consent at any time.
: Not applicable.
: RMM has been the recipient of peer reviewed research grants awarded by Cancer Research UK and National Institute for Health Research to the University of Bristol. The other authors have no competing interests to declare.